Higher levels of treatment satisfaction without compromising efficacy: subcutaneous daratumumab in RRMM Presented ByProf. María-Victoria Mateos , University of Salamanca, Spain TrialPhase 3, COLUMBA ConferenceEHA 2019 TypePeer-reviewed article 9 August 2019 21:36